Advertisement EMD Millipore establishes new facility in China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

EMD Millipore establishes new facility in China

EMD Millipore has established a 28,000sqft Biopharmaceutical Technical and Training Center in Shanghai, China to support area biopharmaceutical manufacturers.

With this new facility, EMD Millipore expects to offer training and validation services to its customers operating in China.

The facility will allow local and regional customers to evaluate, explore and optimize their upstream and downstream processes as well as environmental monitoring processes with the support of EMD Millipore’s local, regional and international experts

EMD Millipore Process Solutions business head Jean-Paul Mangeolle said with this new Biopharmaceutical Technical Center they can support and even train their pharmaceutical customers to meet the new Chinese and global regulations.

"Today we have taken a significant step not only expanding our 30 years of local offerings in China, but also to support the effort to produce safe, quality drugs in this important and growing region," Mangeolle said.